Maryam Eftekhar, Maryam Farid Mojtahedi, Sepideh Miraj, Malihe Omid
Background: Gonadotropin-releasing hormone agonists (GnRH-a) was increasingly used for triggering oocyte maturationfor the prevention of ovarian hyperstimulation syndrome. Studies suggest that GnRH-a might be used as a better trigger agent since it causes both Luteinizing hormone and follicle stimulating hormone release from a physiologic natural cycle. Objective: The aim of this study was to evaluate the effect of dual-triggering in assisted reproductive technology outcomes...
July 2017: International Journal of Reproductive Biomedicine (Yazd, Iran)